Mira Pharmaceuticals (MIRA) Cash & Current Investments (2022 - 2025)

Mira Pharmaceuticals has disclosed Cash & Current Investments across 4 years of filings, most recently posting $11.0 million for Q4 2025.

• Cash & Current Investments for Q4 2025 came in at $11.0 million, up 289.35% year-over-year; the trailing twelve-month figure through Dec 2025 was $11.0 million (up 289.35% YoY), and the FY2025 annual result was $11.0 million, up 289.35% from the prior year.
• Cash & Current Investments came in at $11.0 million for Q4 2025 at Mira Pharmaceuticals, up from $7.5 million in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $11.0 million in Q4 2025 to a low of $1349.0 in Q1 2023.
• The 4-year median for Cash & Current Investments is $2.0 million (2024), against an average of $3.1 million.
• Across the five-year window, Cash & Current Investments tumbled 96.99% in 2023 and jumped 259351.45% in 2024, its largest moves.
• Mira Pharmaceuticals' Cash & Current Investments stood at $350978.0 in 2022, then soared by 1211.35% to $4.6 million in 2023, then sank by 38.45% to $2.8 million in 2024, then jumped by 289.35% to $11.0 million in 2025.
• The last three Cash & Current Investments figures came in at $11.0 million (Q4 2025), $7.5 million (Q3 2025), and $730475.0 (Q2 2025), per Business Quant data.